Company Filing History:
Years Active: 2018-2020
Title: Christina Wang: Innovator in Cardiotoxicity Reduction
Introduction
Christina Wang is a prominent inventor based in Long Beach, California. She has made significant contributions to the field of medical research, particularly in the area of cardiotoxicity associated with chemotherapy treatments. With a total of 2 patents, her work focuses on innovative methods to enhance patient care during cancer treatment.
Latest Patents
Christina Wang's latest patents include groundbreaking methods for reducing cardiotoxicity from chemotherapy by administering humanin analog compositions. These compositions are designed to protect cardiac function in patients undergoing anti-cancer therapies. Additionally, her patent on humanin, analogs, and cancer treatment methods outlines ways to enhance the effectiveness of chemotherapy by using humanin polypeptides in treatment regimens.
Career Highlights
Wang is affiliated with the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, where she conducts her research. Her work has garnered attention for its potential to improve the quality of life for cancer patients by mitigating the harmful side effects of chemotherapy.
Collaborations
Christina collaborates with esteemed colleagues such as Ronald S. Swerdloff and YanHe Lue, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Christina Wang's contributions to the field of cardiotoxicity reduction in chemotherapy highlight her dedication to improving patient outcomes. Her innovative approaches and collaborative efforts position her as a key figure in medical research.